NCT01480336View on ClinicalTrials.gov

The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot

NACompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Arrhythmia

Interventions

DRUG

Amiodarone Plus Ranolazine

Ranolazine 500mg by mouth twice daily

DRUG

Amiodarone with Placebo

stabel dose of amiodarone as prescribed by cardiologist

Trial Locations (1)

06102

Hartford Hospital, Hartford

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Hartford Hospital

OTHER